Evidence map›Paper›PMID 30726504›Full record

SynthesisJAMA neurology2019

Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.

Sandro Marini, Katherine Crawford, Andrea Morotti, Myung J Lee, Alessandro Pezzini, Charles J Moomaw, Matthew L Flaherty, Joan Montaner, Jaume Roquer, Jordi Jimenez-Conde and 43 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in JAMA neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 6 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 6 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Independent effects of white matter lesion volume and APOE ɛ4 on ARIA-H in A4 Study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  8. Apolipoprotein E (Genes · 2026
    Article
  9. Genetics of intracerebral hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  10. Association ofStroke and vascular neurology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Cerebral amyloid angiopathy: a narrative review.Frontiers in aging neuroscience · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Three major effects of APOEFrontiers in aging neuroscience · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 20 institutions in 8 countries.

Sandro MariniCenter for Genomic Medicine, Massachusetts General Hospital, Boston.
Katherine CrawfordCenter for Genomic Medicine, Massachusetts General Hospital, Boston.
Andrea MorottiStroke Unit, IRCCS Mondino Foundation, Pavia, Italy.
Myung J LeeDepartment of Neurology, Massachusetts General Hospital, Boston.
Alessandro PezziniDepartment of Clinical and Experimental Sciences, Neurology Clinic, University of Brescia, Brescia, Italy.
Charles J MoomawDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Matthew L FlahertyDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Joan MontanerNeurovascular Research Laboratory and Neurovascular Unit, Institut de Recerca, Hospital Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
Jaume RoquerDepartment of Neurology, Neurovascular Research Unit, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain.
Jordi Jimenez-CondeDepartment of Neurology, Neurovascular Research Unit, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain.
Eva Giralt-SteinhauerDepartment of Neurology, Neurovascular Research Unit, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain.
Roberto ElosuaDepartment of Neurology, Neurovascular Research Unit, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain.
Elisa Cuadrado-GodiaDepartment of Neurology, Neurovascular Research Unit, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain.
Carolina Soriano-TarragaDepartment of Neurology, Neurovascular Research Unit, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Autonoma de Barcelona, Barcelona, Spain.
Agnieszka SlowikDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Jeremiasz M JagiellaDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Joanna PeraDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Andrzej UrbanikDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Alexander PichlerDepartment of Neurology, Jagiellonian University Medical College, Krakow, Poland.
Björn M HansenDepartment of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.
Jacob L McCauleyJohn P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami.
David L TirschwellStroke Center, Harborview Medical Center, University of Washington, Seattle.
Magdy SelimDepartment of Neurology, Stroke Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Devin L BrownCardiovascular Center, University of Michigan, Ann Arbor.
Scott L SillimanDepartment of Neurology, University of Florida College of Medicine, Jacksonville.
Bradford B WorrallDepartment of Neurology and Public Health Sciences, University of Virginia Health System, Charlottesville.
James F MeschiaDepartment of Neurology, Mayo Clinic, Jacksonville, Florida.
Chelsea S KidwellDepartment of Neurology, University of Arizona, Tucson.
Fernando D TestaiDepartment of Neurology and Rehabilitation, University of Illinois College of Medicine, Chicago.
Steven J KittnerDepartment of Neurology, Baltimore Veterans Administration Medical Center and University of Maryland School of Medicine, Baltimore.
Helena SchmidtDepartment of Neurology, Medical University of Graz, Graz, Austria.
Christian EnzingerDepartment of Neurology, Medical University of Graz, Graz, Austria.
Ian J DearyCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom.
Kristiina RannikmaeCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Neshika SamarasekeraCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Rustam Al-Shahi SalmanCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Catherine L SudlowCentre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.
Catharina J M KlijnDepartment of Neurology, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
Koen M van NieuwenhuizenDepartment of Neurology, Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
Israel Fernandez-CadenasNeurovascular Research Laboratory and Neurovascular Unit, Institut de Recerca, Hospital Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
Pilar DelgadoNeurovascular Research Laboratory and Neurovascular Unit, Institut de Recerca, Hospital Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
Bo NorrvingDepartment of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.
Arne LindgrenDepartment of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.
Joshua N GoldsteinDepartment of Neurology, Massachusetts General Hospital, Boston.
Anand ViswanathanDepartment of Neurology, Massachusetts General Hospital, Boston.
Steven M GreenbergDepartment of Neurology, Massachusetts General Hospital, Boston.
Guido J FalconeDivision of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
Alessandro BiffiDivision of Behavioral Neurology, Massachusetts General Hospital, Boston.
Carl D LangefeldCenter for Public Health Genomics and Department of Biostatistical Sciences, Wake Forest University, Winston-Salem, North Carolina.
Daniel WooDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Jonathan RosandCenter for Genomic Medicine, Massachusetts General Hospital, Boston.
Christopher D AndersonCenter for Genomic Medicine, Massachusetts General Hospital, Boston.
International Stroke Genetics Consortium
Massachusetts General Hospital · USJagiellonian University · PLUniversity of Edinburgh · GBHospital del Mar Research Institute · ESUniversity of Cincinnati Medical Center · USVall d'Hebron Institut de Recerca · ESBroad Institute · USMedical University of Graz · ATSkåne University Hospital · SEUniversitat Autònoma de Barcelona · ESBeth Israel Deaconess Medical Center · USFlorida College · USJacksonville College · USLund University · SERadboud University Nijmegen · NLUniversity Medical Center Utrecht · NLUniversity of Arizona · USUniversity of Brescia · ITUniversity of Illinois Chicago · USUniversity of Maryland, Baltimore · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH)U01NS069763 · NINDS · UNIVERSITY OF CINCINNATI · PI ANDERSON, CHRISTOPHER DAVID, DEMEL, STACIE · 2010 to 2024
$34.2M
Recurrent Hemorrhagic Stroke in Minority PopulationsR01NS093870 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI JONATHAN ROSAND, Amytis Towfighi · 2016 to 2026
$12.3M
Vascular Dysfunction in Cerebral Amyloid AngiopathyR01AG026484 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI GREENBERG, STEVEN M · 2005 to 2019
$7.5M
Vascular Pathology in Early and Asymptomatic Cerebral Amyloid AngiopathyR01AG047975 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI VISWANATHAN, ANAND · 2014 to 2025
$7.5M
Genetic and Environmental Risk Factors for Hemorrhagic StrokeU01NS036695 · NINDS · UNIVERSITY OF CINCINNATI · PI ROSAND, JONATHAN, WOO, DANIEL · 2016 to 2020
$7.0M
Sequencing Annotation and Functional Analysis in Risk of Intracerebral HemorrhageR01NS103924 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANDERSON, CHRISTOPHER DAVID · 2018 to 2022
$3.4M
Genetic Analyses of Lipids in Cerebral Hemorrhage and Small Vessel DiseaseK23NS086873 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANDERSON, CHRISTOPHER DAVID · 2014 to 2018
$951k
Biotechnology and Biological Sciences Research Council BB/F019394/1Medical Research Council G0701075Medical Research Council G0900428Medical Research Council G0901254Medical Research Council G1001245Medical Research Council G1002605Medical Research Council MR/K01417X/1Medical Research Council MR/K026992/1Medical Research Council MR/L501542/1Medical Research Council MR/M013111/1Medical Research Council MR/N026004/1Medical Research Council MR/S004130/1NCATS NIH HHS UL1 TR001863NIA NIH HHS R01 AG026484NIA NIH HHS R01 AG047975NINDS NIH HHS K23 NS086873NINDS NIH HHS R01 NS093870NINDS NIH HHS R01 NS103924NINDS NIH HHS U01 NS036695NINDS NIH HHS U01 NS069763Parkinson's UK G-0907The Dunhill Medical Trust R380R/1114
6 · The paper itself

Abstract

Importance: Genetic studies of intracerebral hemorrhage (ICH) have focused mainly on white participants, but genetic risk may vary or could be concealed by differing nongenetic coexposures in nonwhite populations. Transethnic analysis of risk may clarify the role of genetics in ICH risk across populations. Objective: To evaluate associations between established differences in ICH risk by race/ethnicity and the variability in the risks of apolipoprotein E (APOE) ε4 alleles, the most potent genetic risk factor for ICH. Design, Setting, and Participants: This case-control study of primary ICH meta-analyzed the association of APOE allele status on ICH risk, applying a 2-stage clustering approach based on race/ethnicity and stratified by a contributing study. A propensity score analysis was used to model the association of APOE with the burden of hypertension across race/ethnic groups. Primary ICH cases and controls were collected from 3 hospital- and population-based studies in the United States and 8 in European sites in the International Stroke Genetic Consortium. Participants were enrolled from January 1, 1999, to December 31, 2017. Participants with secondary causes of ICH were excluded from enrollment. Controls were regionally matched within each participating study. Main Outcomes and Measures: Clinical variables were systematically obtained from structured interviews within each site. APOE genotype was centrally determined for all studies. Results: In total, 13 124 participants (7153 [54.5%] male with a median [interquartile range] age of 66 [56-76] years) were included. In white participants, APOE ε2 (odds ratio [OR], 1.49; 95% CI, 1.24-1.80; P < .001) and APOE ε4 (OR, 1.51; 95% CI, 1.23-1.85; P < .001) were associated with lobar ICH risk; however, within self-identified Hispanic and black participants, no associations were found. After propensity score matching for hypertension burden, APOE ε4 was associated with lobar ICH risk among Hispanic (OR, 1.14; 95% CI, 1.03-1.28; P = .01) but not in black (OR, 1.02; 95% CI, 0.98-1.07; P = .25) participants. APOE ε2 and ε4 did not show an association with nonlobar ICH risk in any race/ethnicity. Conclusions and Relevance: APOE ε4 and ε2 alleles appear to affect lobar ICH risk variably by race/ethnicity, associations that are confirmed in white individuals but can be shown in Hispanic individuals only when the excess burden of hypertension is propensity score-matched; further studies are needed to explore the interactions between APOE alleles and environmental exposures that vary by race/ethnicity in representative populations at risk for ICH.

Indexed as

Black or African AmericanCerebral HemorrhageGenetic Predisposition to DiseaseHispanic or LatinoHypertensionWhite PeopleAgedAged, 80 and overApolipoproteins ECase-Control StudiesFemaleHumansMaleMiddle AgedRisk FactorsUnited StatesApoE protein, humanApolipoproteins E

Identifiers

PMID30726504
PMCPMC6459133
OpenAlexW2911419914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.